Microbiota and non-alcoholic fatty liver disease Mikrobiota und nichtalkoholische Fettlebererkrankung
Link A, Thon C, Sydor S, Canbay A (2019)
Publication Type: Journal article, Review article
Publication year: 2019
Journal
Book Volume: 14
Pages Range: 179-184
Journal Issue: 3
DOI: 10.1007/s11377-019-0348-z
Abstract
Non-alcoholic fatty liver disease (NAFLD) has received increased attention during the last 10 years. Due to epidemic increases of obesity, metabolic syndrome and their negative effects on the liver, the number of patients with liver diseases including NAFLD or hepatocellular carcinoma (HCC) is steadily growing. Meanwhile, about 25% of the population suffer from fatty liver. In the future, it is crucial to identify the ways to stop and reverse this trend. In this context, in addition to the healthy diet, weight loss and physical activity especially the gut microbiota and the gut–liver axis play a key role in the development and progression of liver diseases. In this review, we provide the current scientific evidence to microbiota and NAFLD with a main focus on the relevance for practicing physicians. Here we present the most important developments from in vivo and translational research and address the potential relevance for the treatment of NAFLD.
Involved external institutions
Germany (DE)How to cite
APA:
Link, A., Thon, C., Sydor, S., & Canbay, A. (2019). Microbiota and non-alcoholic fatty liver disease Mikrobiota und nichtalkoholische Fettlebererkrankung. Gastroenterologe, 14(3), 179-184. https://doi.org/10.1007/s11377-019-0348-z
MLA:
Link, A., et al. "Microbiota and non-alcoholic fatty liver disease Mikrobiota und nichtalkoholische Fettlebererkrankung." Gastroenterologe 14.3 (2019): 179-184.
BibTeX: Download